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Clinics and pathology

Disease
The frequency of 7q deletions in unseletced NHL is less than 5%; an association with splenic marginal zone B-cell lymphomas (MZBCL) was established, with a 20-30% incidence; sensitive molecular genetic studies found a 40% incidence in splenic MZBCL, as against a 7% incidence in other forms of NHL
Prognosis
There may be an association of 7q-with tumor progression or transformation into a high-grade MZBCL
Cytogenetics
Cytogenetics morphological
7q deletions or unbalanced 7q translocations in NHL usually involve a relatively large segment, usually centered around the 7q22-q32 region
Cytogenetics molecular
conventional G-or R-banded preparations detect the majority of cases; however some patients with submicroscopic deletion were detected by FISH or loss-of-heterozigosity studies
Genes involved and proteins
Note the involved gene(s) are unknown; the minimal region of deletion in MZBCL carrying a 7q-chromosome was narrowed down to a 5cM segment defined by the D7S685 and D7S514 markers; homozygous deletion of the D7S685 was reported, suggesting that a tumor suppressor gene relevant to lymphomagenesis may be located in this region; a recurrent 7q21 translocation involving a small 3.6 Kb segment upstream of the cyclin-dependent kinase 6 gene (CDK6), with resultant CDK6 overexpression, was described
